ImmunityBio (IBRX) Prepaid Assets (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Prepaid Assets of $28.3 million for Q1 2026, up 1100.72% year-over-year from $2.4 million in Q1 2025, and up 1223.33% quarter-over-quarter from $2.1 million in Q4 2025.
ImmunityBio (IBRX) Prepaid Assets (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Prepaid Assets for 13 consecutive years, with $28.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 1100.72% year-over-year to $28.3 million; the TTM figure through Mar 2026 stood at $28.3 million (up 1100.72% YoY), while the FY2025 annual figure was $2.1 million, down 91.05% from the prior year.
- Prepaid Assets climbed to $28.3 million in Q1 2026 per IBRX's latest filing, from $2.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $32.9 million in Q3 2025 and bottomed at $1.4 million in Q3 2024.
- Historically, Prepaid Assets has averaged $14.5 million across 5 years, with a median of $16.1 million in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 2732.34% — and 2024, when it tumbled 94.05%.
- ImmunityBio's Prepaid Assets stood at $2.0 million in 2022, then surged by 1193.73% to $25.6 million in 2023, then dropped by 6.84% to $23.9 million in 2024, then slumped by 91.05% to $2.1 million in 2025, then soared by 1223.33% to $28.3 million in 2026.
- Business Quant data shows IBRX's Prepaid Assets at $28.3 million in Q1 2026, $2.1 million in Q4 2025, and $32.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.82 Mn |
| Mar 31, 2026 | 28.25 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 32.95 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 23.85 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 20.98 Mn |
| Mar 31, 2024 | 23.09 Mn |
| Dec 31, 2023 | 25.60 Mn |
| Sep 30, 2023 | 22.96 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Sep 30, 2022 | 3.24 Mn |
| Jun 30, 2022 | 30.60 Mn |
| Mar 31, 2022 | 16.12 Mn |
| Dec 31, 2021 | 15.90 Mn |
| Sep 30, 2021 | 255,000.00 |